Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
323.50
-1.30
(-0.40%)
At close: February 20 at 5:26:17 PM GMT+1
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
YDO1.MU | -- | -- | -- | -- |
S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
Maintains | HC Wainwright & Co.: Buy to Buy | 1/14/2025 |
Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
Reiterates | Cantor Fitzgerald: Neutral | 11/20/2024 |
Maintains | B. Riley Securities: Neutral to Neutral | 11/5/2024 |
Maintains | UBS: Buy to Buy | 11/1/2024 |
Maintains | Oppenheimer: Outperform to Outperform | 10/23/2024 |
Related Tickers
1VT.F Viking Therapeutics, Inc.
30.21
-4.10%
1VT.MU Viking Therapeutics Inc
31.24
-4.64%
1VT.BE Viking Therapeutics Inc
31.00
-0.39%
XBIO Xenetic Biosciences, Inc.
4.0300
-1.95%
QLGN Qualigen Therapeutics, Inc.
3.6200
-2.43%
AADI Aadi Bioscience, Inc.
2.8600
-0.35%
NAUT Nautilus Biotechnology, Inc.
1.6000
-4.19%
AVIR Atea Pharmaceuticals, Inc.
3.1400
+1.62%
KPRX Kiora Pharmaceuticals, Inc.
3.5100
0.00%
DRMA Dermata Therapeutics, Inc.
1.2100
0.00%